HOME Top Market Reports Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022

Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: February 2018
Report Code: BT 2680

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global oligonucleotide synthesis market is valued at USD 1.33 Billion in 2016 and is projected to reach USD 2.46 Billion by 2022, at a CAGR of 10.9%. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.

The objectives of this study are as follows:

  • To define, describe, and forecast the global oligonucleotide synthesis market on the basis of product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders
  • To forecast the size of the market with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments in the market, such as joint ventures, mergers and acquisitions, product launches, expansions, and R&D activities

Research Methodology

The study estimates the market size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include research scientists, biotechnologists, synthetic biologists, and academic research institutes.

For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the oligonucleotide synthesis market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Secondary sources such as directories; databases such as D&B, Bloomberg Business, and Factiva; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies were referred.

Oligonucleotide Synthesis Market

To know about the assumptions considered for the study, download the pdf brochure

The oligonucleotide synthesis market is highly competitive with the presence of several small and big players. Prominent players in the market include Integrated DNA Technologies (IDT) (US), Sigma-Aldrich Corporation (US) (part of Merck KGaA), Eurogentec (Belgium), Eurofins Genomics (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), BioAutomation (US), LGC Biosearch Technologies (US), GeneDesign (Japan), GE Healthcare (US), TriLink BioTechnologies (US), GenScript (China), Nitto Denko Avecia (US), ATDBio (UK), Bio-Synthesis (US), IBA GmbH (Germany), Gene Link (US), and AITbiotech Pte. (Singapore).

Target Audience for this Report:

  • Life science instrumentation and reagent companies
  • Pharmaceutical and biotechnology companies
  • Hospitals and clinics
  • Academic researchers and government research organizations
  • Private research institutes
  • Custom oligonucleotide service providers
  • Contract manufacturing organizations (CMOs)
  • Oligonucleotide equipment manufacturers
  • Contract research organizations (CROs)
  • Market research and consulting firms
  • Venture capitalists

Scope of the Report

This report categorizes the market into following segments and subsegments:

Oligonucleotide Synthesis Market, by Product

  • Synthesized Oligonucleotides
    • By Product
      • Primers
      • Probes
      • Large-scale Synthesis Oligonucleotides
      • Intermediate-scale Synthesis Oligonucleotides
      • Linkers & Adaptors
    • By Service
      • Custom Oligos
      • Pre-designed Oligos
  • Reagents
  • Equipment

Oligonucleotide Synthesis Market, by Application

  • Research
    • PCR
    • QPCR
    • DNA Sequencing
    • Gene Synthesis
    • Other Research Applications [Nucleic Acid-based Testing, Isothermal Nucleic Acid Technology, Binding Studies, Gel Shift Assays, and Fluorescence In Situ Hybridization (FISH)]
  • Diagnostics
  • Therapeutics
    • DNA/Antisense Oligos
    • RNAi
    • Nucleic Acid Aptamers
    • Immunotherapy

Oligonucleotide Synthesis Market, by End User

  • Academic Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Other End Users (Hospitals and Private Research Laboratories)

Oligonucleotide Synthesis Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • RoE
  • Asia Pacific
    • China
    • India
    • Japan
    • RoAPAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East and Africa (MEA)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.

The following customization options are available for this report.

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 22)
    1.1 Objectives of the Study
    1.2 Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 26)
    2.1 Research Data
    2.2 Secondary Data
           2.2.1 Secondary Sources
    2.3 Primary Data
           2.3.1 Key Data From Primary Sources
           2.3.2 Key Industry Insights
    2.4 Market Size Estimation
           2.4.1 Market Size Estimation: Bottom-Up Approach
           2.4.2 Market Size Estimation: Top-Down Approach
    2.5 Market Breakdown and Data Triangulation
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 34)

4 Premium Insights (Page No. - 39)
    4.1 Attractive Opportunities in Oligonucleotide Synthesis Market
    4.2 Oligonucleotides Synthesis Market, By Synthesized Oligonucleotides Products
    4.3 Market, By Synthesized Oligonucleotides Type
    4.4 Europe: Market, By Research Application and Country
    4.5 Oligonucleotide Synthesis Market, By Therapeutic Application
    4.6 Market, By End User
    4.7 Geographic Snapshot: Market

5 Market Overview (Page No. - 45)
    5.1 Introduction
    5.2 Market Drivers
           5.2.1 Increasing Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
           5.2.2 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies
           5.2.3 Rise in Venture Capital Investments
    5.3 Market Restraints
           5.3.1 Price Erosion of Synthesized Oligonucleotides
           5.3.2 Lack of A Unified Set of Regulations for Therapeutic Oligonucleotides
    5.4 Market Opportunities
           5.4.1 Emerging Asian Markets
    5.5 Market Challenges
           5.5.1 Large-Scale Synthesis of Oligonucleotides
           5.5.2 Delivery of Oligonucleotide Drugs to Specific Targets
    5.6 Industry Trends

6 Oligonucleotide Synthesis Market, By Product (Page No. - 52)
    6.1 Introduction
    6.2 Synthesized Oligonucleotides
           6.2.1 By Product
                    6.2.1.1 Primers
                    6.2.1.2 Probes
                    6.2.1.3 Large-Scale Synthesis Oligonucleotides
                    6.2.1.4 Intermediate-Scale Synthesis Oligonucleotides
                    6.2.1.5 Linkers & Adaptors
           6.2.2 By Type
                    6.2.2.1 Custom Oligonucleotides
                    6.2.2.2 Pre-Designed Oligonucleotides
    6.3 Reagents
    6.4 Equipment

7 Oligonucleotide Synthesis Market, By Application (Page No. - 82)
    7.1 Introduction
    7.2 Research
           7.2.1 PCR
           7.2.2 QPCR
           7.2.3 Sequencing
           7.2.4 Gene Synthesis
           7.2.5 Other Research Applications
    7.3 Diagnostics
    7.4 Therapeutics
           7.4.1 RNAi
           7.4.2 Nucleic Acid Aptamers
           7.4.3 DNA/Antisense Oligonucleotides
           7.4.4 Immunotherapy Applications

8 Oligonucleotide Synthesis Market, By End User (Page No. - 115)
    8.1 Introduction
    8.2 Academic Research Institutes
    8.3 Pharmaceutical and Biotechnology Companies
    8.4 Diagnostic Laboratories
    8.5 Other End Users

9 Oligonucleotide Synthesis Market, By Region (Page No. - 128)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 France
           9.3.3 UK
           9.3.4 Rest of Europe (RoE)
    9.4 Asia Pacific (APAC)
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Rest of Asia Pacific (RoAPAC)
    9.5 Latin America
           9.5.1 Brazil
           9.5.2 Mexico
           9.5.3 Rest of Latin America
    9.6 Middle East & Africa

10 Competitive Landscape (Page No. - 203)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Scenario
             10.3.1 Partnerships, Agreements, Contracts, and Collaborations
             10.3.2 Product Launches, Upgrades, and Approvals
             10.3.3 Expansions
             10.3.4 Acquisitions

11 Company Profiles (Page No. - 210)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     11.1 Integrated DNA Technologies
     11.2 Merck KGaA
     11.3 Eurofins Genomics
     11.4 Thermo Fisher Scientific
     11.5 Bioautomation
     11.6 Agilent Technologies
     11.7 Eurogentec
     11.8 GE Healthcare
     11.9 LGC Biosearch Technologies
     11.10 Nitto Denko Avecia
     11.11 Genscript
     11.12 Genedesign (Part of Ajinomoto)
     11.13 TriLink Biotechnologies (Part of Maravai Lifesciences)
     11.14 Bio-Synthesis
     11.15 ATDBio

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 264)
     12.1 Insights From Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports
     12.7 Author Details


List of Tables (230 Tables)

Table 1 Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Region, 2015–2022 (USD Million)
Table 2 North America: Market for Synthesized Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 3 Europe: Market for Synthesized Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 4 Asia Pacific: Market for Synthesized Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 5 Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Product Type, 2015–2022 (USD Million)
Table 6 Market for Primers, By Region, 2015–2022 (USD Million)
Table 7 North America: Market for Primers, By Country, 2015–2022 (USD Million)
Table 8 Europe: Market for Primers, By Country, 2015–2022 (USD Million)
Table 9 Asia Pacific: Oligonucleotide Synthesis Market for Primers, By Country, 2015–2022 (USD Million)
Table 10 Market for Probes, By Region, 2015–2022 (USD Million)
Table 11 North America: Market for Probes, By Country, 2015–2022 (USD Million)
Table 12 Europe: Oligonucleotide Synthesis Market for Probes, By Country, 2015–2022 (USD Million)
Table 13 Asia Pacific: Market for Probes, By Country, 2015–2022 (USD Million)
Table 14 Market for Large-Scale Synthesis Oligonucleotides, By Region, 2015–2022 (USD Million)
Table 15 North America: Oligonucleotide Synthesis Market for Large-Scale Synthesis Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 16 Europe: Market for Large-Scale Synthesis Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 17 Asia Pacific: Market for Large-Scale Synthesis Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 18 Market for Intermediate-Scale Synthesis Oligonucleotides, By Region, 2015–2022 (USD Million)
Table 19 North America: Market for Intermediate-Scale Synthesis Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 20 Europe: Oligonucleotide Synthesis Market for Intermediate-Scale Synthesis Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 21 Asia Pacific: Market for Intermediate-Scale Synthesis Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 22 Oligonucleotide Synthesis Market for Linkers & Adaptors, By Region, 2015–2022 (USD Million)
Table 23 North America: Market for Linkers & Adaptors, By Country, 2015–2022 (USD Million)
Table 24 Europe: Market for Linkers & Adaptors, By Country, 2015–2022 (USD Million)
Table 25 Asia Pacific: Market for Linkers & Adaptors, By Country, 2015–2022 (USD Million)
Table 26 Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 27 Market for Custom Oligonucleotides, By Region, 2015–2022 (USD Million)
Table 28 North America: Market for Custom Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 29 Europe: Oligonucleotide Synthesis Market for Custom Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 30 Asia Pacific: Market for Custom Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 31 Market for Pre-Designed Oligonucleotides, By Region, 2015–2022 (USD Million)
Table 32 North America: Market for Pre-Designed Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 33 Europe: Oligonucleotide Synthesis Market for Pre-Designed Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 34 Asia Pacific: Market for Pre-Designed Oligonucleotides, By Country, 2015–2022 (USD Million)
Table 35 Oligonucleotide Synthesis Market for Reagents, By Region, 2015–2022 (USD Million)
Table 36 North America: Market for Reagents, By Country, 2015–2022 (USD Million)
Table 37 Europe: Market for Reagents, By Country, 2015–2022 (USD Million)
Table 38 Asia Pacific: Market for Reagents, By Country, 2015–2022 (USD Million)
Table 39 Market for Equipment, By Region, 2015–2022 (USD Million)
Table 40 North America: Market for Equipment, By Country, 2015–2022 (USD Million)
Table 41 Europe: Market for Equipment, By Country, 2015–2022 (USD Million)
Table 42 Asia Pacific: Oligonucleotide Synthesis Market for Equipment, By Country, 2015–2022 (USD Million)
Table 43 Market, By Application, 2015-2022 (USD Million)
Table 44 Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 45 Market for Research Applications, By Region, 2015-2022 (USD Million)
Table 46 North America: Oligonucleotide Synthesis Market for Research Applications, By Country, 2015-2022 (USD Million)
Table 47 Europe: Market for Research Applications, By Country, 2015-2022 (USD Million)
Table 48 Asia Pacific: Oligonucleotide Synthesis Market for Research Applications, By Country, 2015-2022 (USD Million)
Table 49 Market for PCR Applications, By Region, 2015-2022 ( USD Million)
Table 50 North America: Market for PCR Applications, By Country, 2015-2022 (USD Million)
Table 51 Europe: Oligonucleotide Synthesis Market for PCR Applications, By Country, 2015-2022 (USD Million)
Table 52 Asia Pacific: Market for PCR Applications, By Country, 2015-2022 (USD Million)
Table 53 Market for QPCR Applications, By Region, 2015-2022 (USD Million)
Table 54 North America: Market for QPCR Applications, By Country, 2015-2022 (USD Million)
Table 55 Europe: Market for QPCR Applications, By Country, 2015-2022 (USD Million)
Table 56 Asia Pacific: Market for QPCR Applications, By Country, 2015-2022 (USD Million)
Table 57 Oligonucleotide Synthesis Market for Sequencing Applications, By Region, 2015–2022(USD Million)
Table 58 North America: Market for Sequencing Applications, By Country, 2015-2022 (USD Million)
Table 59 Europe: Market for Sequencing Applications, By Country, 2015–2022 (USD Million)
Table 60 Asia Pacific: Market for Sequencing Applications, By Country, 2015–2022 (USD Million)
Table 61 Oligonucleotide Synthesis Market for Gene Synthesis Applications, By Region, 2015–2022 (USD Million)
Table 62 North America: Market for Gene Synthesis Applications, By Country, 2015–2022 (USD Million)
Table 63 Europe: Market for Gene Synthesis Applications, By Country, 2015–2022 (USD Million)
Table 64 Asia Pacific: Market for Gene Synthesis Applications, By Country, 2015–2022 (USD Million)
Table 65 Oligonucleotide Synthesis Market for Other Research Applications, By Region, 2015–2022 (USD Million)
Table 66 North America: Market for Other Research Applications, By Country, 2015–2022 (USD Million)
Table 67 Europe: Market for Other Research Applications, By Country, 2015–2022 (USD Million)
Table 68 Asia Pacific: Market for Other Research Applications, By Country, 2015–2022 (USD Million)
Table 69 Oligonucleotide Synthesis Market for Diagnostic Applications, By Region, 2015–2022 (USD Million)
Table 70 North America: Market for Diagnostic Applications, By Country, 2015–2022 (USD Million)
Table 71 Europe: Market for Diagnostic Applications, By Country, 2015–2022 (USD Million)
Table 72 Asia Pacific: Market for Diagnostic Applications, By Country, 2015–2022 (USD Million)
Table 73 Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 74 Market for Therapeutic Applications, By Region, 2015–2022 (USD Million)
Table 75 North America: Oligonucleotide Synthesis Market for Therapeutic Applications, By Country, 2015–2022 (USD Million)
Table 76 Europe: Market for Therapeutic Applications, By Country, 2015–2022 (USD Million)
Table 77 Asia Pacific: Market for Therapeutic Applications, By Country, 2015–2022 (USD Million)
Table 78 Oligonucleotide Synthesis Market for RNAi Applications, By Region, 2015–2022 (USD Million)
Table 79 North America: Market for RNAi Applications, By Country, 2015–2022 (USD Million)
Table 80 Europe: Market for RNAi Applications, By Country, 2015–2022 (USD Million)
Table 81 Asia Pacific: Market for RNAi Applications, By Country, 2015–2022 (USD Million)
Table 82 Oligonucleotide Synthesis Market for Nucleic Acid Aptamer Applications, By Region, 2015–2022 (USD Million)
Table 83 North America: Market for Nucleic Acid Aptamer Applications, By Country, 2015–2022 (USD Million)
Table 84 Europe: Market for Nucleic Acid Aptamer Applications, By Country, 2015–2022 (USD Million)
Table 85 Asia Pacific: Oligonucleotide Synthesis Market for Nucleic Acid Aptamer Applications, By Country, 2015–2022 (USD Million)
Table 86 Market for DNA/Antisense Oligo Applications, By Region, 2015–2022 (USD Million)
Table 87 North America: Market for DNA/Antisense Oligo Applications, By Country, 2015–2022 (USD Million)
Table 88 Europe: Oligonucleotide Synthesis Market for DNA/Antisense Oligo Applications, By Country, 2015–2022 (USD Million)
Table 89 Asia Pacific: Market for DNA/Antisense Oligo Applications, By Country, 2015–2022 (USD Million)
Table 90 Market for Immunotherapy Applications, By Region, 2015–2022 (USD Thousand)
Table 91 North America: Market for Immunotherapy Applications, By Country, 2014-2021 (USD Thousand)
Table 92 Europe: Market for Immunotherapy Applications, By Country, 2015–2022 (USD Thousand)
Table 93 Asia Pacific: Oligonucleotide Synthesis Market for Immunotherapy Applications, By Country, 2015–2022 (USD Thousand)
Table 94 Market, By End User,2015–2022 (USD Million)
Table 95 Market for Academic Research Institutes, By Region, 2015–2022 (USD Million)
Table 96 North America: Market for Academic Research Institutes, By Country, 2015–2022 (USD Million)
Table 97 Europe: Oligonucleotide Synthesis Market for Academic Research Institutes, By Country, 2015–2022 (USD Million)
Table 98 Asia Pacific: Market for Academic Research Institutes, By Country, 2015–2022 (USD Million)
Table 99 Market for Pharmaceutical and Biotechnology Companies, By Region, 2015–2022 (USD Million)
Table 100 North America: Oligonucleotide Synthesis Market for Pharmaceutical and Biotechnology Companies, By Country, 2015–2022 (USD Million)
Table 101 Europe: Market for Pharmaceutical and Biotechnology Companies, By Country, 2015–2022 (USD Million)
Table 102 Asia Pacific: Oligonucleotide Synthesis Market for Pharmaceutical and Biotechnology Companies, By Country, 2015–2022 (USD Million)
Table 103 Market for Diagnostic Laboratories, By Region, 2015–2022 (USD Million)
Table 104 North America: Market for Diagnostic Laboratories, By Country, 2015–2022 (USD Million)
Table 105 Europe: Market for Diagnostic Laboratories, By Country, 2015–2022 (USD Million)
Table 106 Asia Pacific: Oligonucleotide Synthesis Market for Diagnostic Laboratories, By Country, 2015–2022 (USD Million)
Table 107 Market for Other End Users, By Region, 2015–2022 (USD Million)
Table 108 North America: Market for Other End Users, By Country, 2015–2022 (USD Million)
Table 109 Europe: Market for Other End Users, By Country, 2015–2022 (USD Million)
Table 110 Asia Pacific: Market for Other End Users, By Country, 2015–2022 (USD Million)
Table 111 Oligonucleotide Synthesis Market, By Region, 2015–2022 (USD Million)
Table 112 North America: Market, By Country, 2015–2022 (USD Million)
Table 113 North America: Market, By Product, 2015–2022 (USD Million)
Table 114 North America: Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 115 North America: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 116 North America: Market, By Application, 2015–2022 (USD Million)
Table 117 North America: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 118 North America: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 119 North America: Market, By End User, 2015–2022 (USD Million)
Table 120 US: Market, By Product, 2015–2022 (USD Million)
Table 121 US: Market for Synthesized Oligonucleotides, By Product 2015–2022 (USD Million)
Table 122 US: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 123 US: Market, By Application, 2015–2022 (USD Million)
Table 124 US: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 125 US: Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 126 US: Market, By End User, 2015–2022 (USD Million)
Table 127 Canada: Market, By Product, 2015–2022 (USD Million)
Table 128 Canada: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Product, 2015–2022 (USD Million)
Table 129 Canada: Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 130 Canada: Market, By Application, 2015–2022 (USD Million)
Table 131 Canada: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 132 Canada: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 133 Canada: Market, By End User, 2015–2022 (USD Million)
Table 134 Europe: Market, By Country, 2015–2022 (USD Million)
Table 135 Europe: Market, By Product, 2015–2022 (USD Million)
Table 136 Europe: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Product, 2015–2022 (USD Million)
Table 137 Europe: Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 138 Europe: Market, By Application, 2015–2022 (USD Million)
Table 139 Europe: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 140 Europe: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 141 Europe: Market, By End User, 2015–2022 (USD Million)
Table 142 Germany: Market, By Product, 2015–2022 (USD Million)
Table 143 Germany: Market for Synthesized Oligonucleotides, By Product, 2015–2022 (USD Million)
Table 144 Germany: Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 145 Germany: Market, By Application, 2015–2022 (USD Million)
Table 146 Germany: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 147 Germany: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 148 Germany: Market, By End User, 2015–2022 (USD Million)
Table 149 France: Market, By Product, 2015–2022 (USD Million)
Table 150 France: Market for Synthesized Oligonucleotides, By Product, 2015–2022 (USD Million)
Table 151 France: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 152 France: Market, By Application, 2015–2022 (USD Million)
Table 153 France: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 154 France: Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 155 France: Market, By End User, 2015–2022 (USD Million)
Table 156 UK: Oligonucleotide Synthesis Market, By Product, 2015–2022 (USD Million)
Table 157 UK: Market for Synthesized Oligonucleotides, By Product, 2015–2022 (USD Million)
Table 158 UK: Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 159 UK: Oligonucleotide Synthesis Market, By Application, 2015–2022 (USD Million)
Table 160 UK: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 161 UK: Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 162 UK: Market, By End User, 2015–2022 (USD Million)
Table 163 RoE: Market, By Product, 2015–2022 (USD Million)
Table 164 RoE: Market for Synthesized Oligonucleotides, By Product, 2015–2022 (USD Million)
Table 165 RoE: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 166 RoE: Market, By Application, 2015–2022 (USD Million)
Table 167 RoE: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 168 RoE: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 169 RoE: Market, By End User, 2015–2022 (USD Million)
Table 170 Asia Pacific: Market, By Country, 2015–2022 (USD Million)
Table 171 Asia Pacific: Market, By Product, 2015–2022 (USD Million)
Table 172 Asia Pacific: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Product, 2015–2022 (USD Million)
Table 173 Asia Pacific: Market for Synthesized Oligonucleotides, By Type,2015–2022 (USD Million)
Table 174 Asia Pacific: Market, By Application, 2015–2022 (USD Million)
Table 175 Asia Pacific: Oligonucleotide Synthesis Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 176 Asia Pacific: Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 177 Asia Pacific: Market, By End User, 2015–2022 (USD Million)
Table 178 China: Market, By Product, 2015–2022 (USD Million)
Table 179 China: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Product, 2015–2022 (USD Million)
Table 180 China: Market for Synthesized Oligonucleotides, By Type 2015–2022 (USD Million)
Table 181 China: Market, By Application, 2015–2022 (USD Million)
Table 182 China: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 183 China: Oligonucleotide Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 184 China: Oligonucleotide Synthesis Market, By End User, 2015–2022 (USD Million)
Table 185 Japan: Market, By Product, 2015–2022 (USD Million)
Table 186 Japan: Market for Synthesized Oligonucleotides, By Product, 2015–2022 (USD Million)
Table 187 Japan: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 188 Japan: Market, By Application, 2015–2022 (USD Million)
Table 189 Japan: Oligonucleotide Synthesis Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 190 Japan: Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 191 Japan: Market, By End User, 2015–2022 (USD Million)
Table 192 India: Market, By Product, 2015–2022 (USD Million)
Table 193 India: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Product, 2015–2022 (USD Million)
Table 194 India: Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 195 India: Oligonucleotide Synthesis Market, By Application, 2015–2022 (USD Million)
Table 196 India: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 197 India: Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 198 India: Market, By End User, 2015–2022 (USD Million)
Table 199 RoAPAC: Oligonucleotide Synthesis Market, By Product, 2015–2022 (USD Million)
Table 200 RoAPAC: Market for Synthesized Oligonucleotides, By Product, 2015–2022 (USD Million)
Table 201 RoAPAC: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 202 RoAPAC: Oligonucleotide Synthesis Market, By Application, 2015–2022 (USD Million)
Table 203 RoAPAC: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 204 RoAPAC: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 205 RoAPAC: Market, By End User, 2015–2022 (USD Million)
Table 206 Latin America: Market, By Country/Region, 2015–2022 (USD Million)
Table 207 Latin America: Market, By Product, 2015–2022 (USD Million)
Table 208 Latin America: Market for Synthesized Oligonucleotides, By Product, 2015–2022 (USD Million)
Table 209 Latin America: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 210 Latin America: Market, By Application, 2015–2022 (USD Million)
Table 211 Latin America: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 212 Latin America: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 213 Latin America: Market, By End User, 2015–2022 (USD Million)
Table 214 Brazil: Market, By Product, 2015–2022 (USD Million)
Table 215 Brazil: Market, By Application, 2015–2022 (USD Million)
Table 216 Brazil: Oligonucleotide Synthesis Market, By End User, 2015–2022 (USD Million)
Table 217 Mexico: Market, By Product, 2015–2022 (USD Million)
Table 218 Mexico: Market, By Application, 2015–2022 (USD Million)
Table 219 Mexico: Market, By End User, 2015–2022 (USD Million)
Table 220 RoLATAM: Oligonucleotide Synthesis Market, By Product, 2015–2022 (USD Million)
Table 221 RoLATAM: Market, By Application, 2015–2022 (USD Million)
Table 222 RoLATAM: Market, By End User, 2015–2022 (USD Million)
Table 223 Middle East & Africa: Oligonucleotide Synthesis Market, By Product, 2015–2022 (USD Million)
Table 224 Middle East & Africa: Oligonucleotide Synthesis for Synthesized Oligonucleotides, Byproduct, 2015–2022 (USD Million)
Table 225 Middle East & Africa: Market for Synthesized Oligonucleotides, By Type, 2015–2022 (USD Million)
Table 226 Middle East & Africa: Oligonucleotide Synthesis Market, By Application, 2015–2022 (USD Million)
Table 227 Middle East & Africa: Market for Research Applications, By Type, 2015–2022 (USD Million)
Table 228 Middle East & Africa: Market for Therapeutic Applications, By Type, 2015–2022 (USD Million)
Table 229 Middle East & Africa: Oligonucleotide Synthesis Market, By End User, 2015–2022 (USD Million)
Table 230 Exchange Rates (Used for the Conversion of Eur to USD)
 

List of Figures (40 Figures)
 
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation Methodology
Figure 4 Synthesized Oligonucleotides Segment to Dominate the Global Oligonucleotide Synthesis Market During the Forecast Period
Figure 5 Intermediate-Scale Synthesis Oligonucleotides Segment to Register the Highest Growth (2017–2022)
Figure 6 Custom Oligos to Dominate the Oligonucleotide Synthesis Market
Figure 7 Research Applications to Dominate the Market in 2017
Figure 8 Diagnostic Laboratories End User Segment to Register the Highest CAGR (2017–2022)
Figure 9 North America to Hold the Largest Share in 2017 and Asia Pacific to Witness the Highest Growth (2017–2022)
Figure 10 Increasing Research Activities and Growth in the Fields of Molecular Diagnostics and Ngs are Driving Market Growth
Figure 11 Primers to Form the Major Contributing Segment of the Synthesized Oligonucleotides Market (2017–2022)
Figure 12 Custom Oligos to Dominate the Synthesized Oligonucleotides Market From 2017 to 2022
Figure 13 PCR to Command the Largest Share of the European Research Applications Market in 2017
Figure 14 RNAi Segment to Register the Highest CAGR During the Forecast Period
Figure 15 Diagnostic Laboratories to Witness Highest Growth Rate During the Forecast Period
Figure 16 China to Grow at the Highest Rate During the Forecast Period
Figure 17 Oligonucleotide Synthesis Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Market: Industry Trends
Figure 19 Synthesized Oligonucleotides to Grow at the Highest CAGR During the Forecast Period
Figure 20 Asia Pacific to Grow at the Highest Rate During the Forecast Period
Figure 21 Custom Oligonucleotides to Command the Largest Share of Synthesized Oligonucleotides Market in 2016
Figure 22 Diagnostic Applications Segment Offers Lucrative Growth Opportunities During the Forecast Period
Figure 23 Oligonucleotide Synthesis Market, By End User, 2017 vs 2022
Figure 24 Asia Pacific to Register Highest CAGR in the Oligonucleotide Synthesis Market for Academic Research Institutes
Figure 25 North America: Oligonucleotide Synthesis Market Snapshot
Figure 26 Europe: Market Snapshot
Figure 27 Asia Pacific: Market Snapshot
Figure 28 Latin America: Oligonucleotide Synthesis Market Snapshot
Figure 29 Middle East & Africa: Market Snapshot
Figure 30 Key Players Adopted Organic as Well as Inorganic Growth Strategies Between 2014 and 2017
Figure 31 Market Evolution Framework
Figure 32 Global Oligonucleotide Synthesis Market Share Analysis, By Key Player, 2016
Figure 33 Merck KGaA: Company Snapshot
Figure 34 Eurofins Scientific Group: Company Snapshot
Figure 35 Thermo Fisher Scientific: Company Snapshot
Figure 36 Agilent Technologies: Company Snapshot
Figure 37 Kaneka: Company Snapshot
Figure 38 General Electric Company (GE): Company Snapshot
Figure 39 Nitto Denko Group: Company Snapshot
Figure 40 Genscript: Company Snapshot

The global oligonucleotide synthesis market is expected to reach USD 2.46 Billion by 2022 from USD 1.47 Billion in 2017 at a CAGR of 10.9%. The growth of this market is mainly driven by the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.

This report segments the market into product, application, end user, and region. Based on product, the market is segmented into synthesized oligonucleotides, reagents, and equipment. In 2017, synthesized oligonucleotides are estimated to account for the largest share of the total market, followed by reagents. The growth of the synthesized oligonucleotides segment is attributed to the increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics.

Based on product, the synthesized oligonucleotides market is segmented into primers, probes, large-scale synthesis oligonucleotides, intermediate-scale synthesis oligonucleotides, and linkers & adaptors. Primers are expected to account for the largest share of the synthesized oligonucleotides market in 2017. The intermediate-scale synthesis oligonucleotides segment is projected to register the highest CAGR, due to the rising demand for synthesized oligonucleotides and innovations in manufacturing techniques to produce intermediate-scale oligonucleotides.

Based on end user, the oligonucleotide synthesis market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. The diagnostic laboratories segment is expected grow at the highest CAGR during the forecast period. This growth is attributed to the rising diagnostic applications of oligonucleotides and the growing field of molecular diagnostics.

Oligonucleotide Synthesis Market

In 2017, North America is expected to dominate the market followed by Europe. Asia Pacific is expected to grow at the highest CAGR during the forecast period. This can be attributed to factors such as the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the APAC region. The increasing focus of prominent players on APAC is also supporting market growth in the region. However, price erosion and a lack of regulations for therapeutic oligonucleotides could hinder the growth of this market to a certain extent.

The oligonucleotide synthesis market is highly competitive with the presence of several small and big players. Prominent players in the market include Agilent Technologies (US), ATDBio (UK), Bio-Synthesis (US), BioAutomation (US), LGC Biosearch Technologies (US), Eurofins Genomics (Germany), Eurogentec (Belgium), GeneDesign (Japan), GE Healthcare (US), GenScript (US), Integrated DNA Technologies (IDT) (US), Nitto Denko Avecia (US), Thermo Fisher Scientific (US), TriLink Biotechnologies (US), and Sigma-Aldrich Corporation (Sigma-Aldrich) (US) (part of Merck KGAA (Germany)).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo